Relaxation therapy studied for brain tumor anxiety – but trial cut short
NCT ID NCT05189366
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding sophrology (a relaxation method using breathing, visualization, and gentle movement) to speech therapy could reduce anxiety in people with aggressive brain tumors. Only 13 patients were enrolled before the trial was stopped early. The goal was to see if this combination improved anxiety levels and quality of life compared to speech therapy alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sophrology (relaxation therapy)
- What this could lead to
- If it had worked, this approach could have offered a simple, drug-free way to reduce anxiety and improve quality of life for brain tumor patients with speech difficulties.
- What could go wrong
- The trial was terminated early and enrolled only 13 people, so results are very limited. It is unclear if sophrology provides any real benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.